Adagene Inc.

ADAG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001818838

SEC filings (opens in a new tab)

In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Adagene Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of ADAG: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	16	15	−1
Shares	8.37M	8.39M	+17.8K (+0.2%)
Value	$67.3M	$29.7M	−$37.6M (−55.9%)

New holders (1)

Institutions that held Adagene Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ADAG in Q1 2022
Institution	Shares	Value	% of portfolio
Geode Capital Management, LLC	10,309	$36.0K	0.00%

Sold out (2)

Institutions that held Adagene Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ADAG in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
OrbiMed Advisors LLC	263,176	$2.12M
Citadel Advisors LLC	16,753	$134.0K